Table 1. Patient baseline characteristics.
| All Patients (n = 70) |
Successful PCI (n = 60) |
Failed PCI (n = 10) |
p Value | |
|---|---|---|---|---|
| Demographics | ||||
| Age (years) | 65.1 ± 8.9 | 65.2 ± 9.0 | 64.2 ± 8.6 | 0.74 |
| Male, n (%) | 59 (84) | 51 (85) | 8 (80) | 0.90 |
| Hypertension, n (%) | 64 (91) | 55 (92) | 9 (90) | 0.86 |
| Diabetes Mellitus, n (%) | 40 (57) | 33 (55) | 7 (70) | 0.38 |
| Dyslipidemia, n (%) | 62 (89) | 53 (88) | 9 (90) | 0.89 |
| Smoking, n (%) | 35 (50) | 30 (50) | 5 (50) | 0.66 |
| Systolic BP (mm Hg) | 131 ± 24 | 132 ± 25 | 125 ± 18 | 0.45 |
| Heart rate (beats/min) | 68±11 | 67±11 | 71±14 | 0.30 |
| Laboratory data | ||||
| Serum creatinine (mg/dL) | 1.1 ± 1.0 | 1.1 ± 1.0 | 1.0 ± 0.7 | 0.66 |
| Medications | ||||
| ACEI and/ or ARB, n (%) | 41 (58) | 35 (58) | 6 (60) | 0.92 |
| Beta-blockers, n (%) | 37 (53) | 32 (53) | 5 (50) | 0.85 |
| Nitrates, n (%) | 27 (39) | 22 (37) | 5 (50) | 0.65 |
| Statin, n (%) | 61 (87) | 52 (87) | 9 (90) | 0.78 |
ARB, angiotensin II receptor blocker; ACEI, angiotensin converting enzyme inhibitor; BP, blood pressure; and PCI, percutaneous coronary intervention